Testing effectiveness (Phase 2)UnknownNCT01120002What this trial is testingEfficacy and Safety of Tamibarotene (OAM80) for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Osaka City University 50
Early research (Phase 1)Study completedNCT01369225What this trial is testingOpen Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 52
Early research (Phase 1)Study completedNCT03635047What this trial is testingA Phase I Study for Safety and Tolerability of AL002.Who this might be right forHealthyAlzheimer Disease Alector Inc. 69
Early research (Phase 1)Study completedNCT01850238What this trial is testingSafety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseWho this might be right forAlzheimer Disease Axon Neuroscience SE 30
Not applicableNo Longer AvailableNCT06961760What this trial is testingExpanded Access Program for CT1812 (Zervimesine)Who this might be right forDementia With Lewy Bodies Cognition Therapeutics
Post-approval studies (Phase 4)Study completedNCT02787746What this trial is testingSafety and Efficacy of Donepezil in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Beijing Friendship Hospital 241
Testing effectiveness (Phase 2)Study completedNCT00257673What this trial is testingSafety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Memory Pharmaceuticals 183
Testing effectiveness (Phase 2)Study completedNCT03055741What this trial is testingStudy of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)Who this might be right forMild-moderate Alzheimer's Disease Daehwa Pharmaceutical Co., Ltd. 180
Large-scale testing (Phase 3)Study completedNCT00053599What this trial is testingCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyWho this might be right forAlzheimer Disease National Institute on Aging (NIA) 400
Large-scale testing (Phase 3)Looking for participantsNCT06976203What this trial is testingEvaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)Who this might be right forAlzheimer's Disease Bristol-Myers Squibb 586
Large-scale testing (Phase 3)Ended earlyNCT02327182What this trial is testingSafety Study of MT-4666 in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Tanabe Pharma Corporation 117
Testing effectiveness (Phase 2)Study completedNCT01782742What this trial is testingBexarotene Amyloid Treatment for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT01436045What this trial is testingSafety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.Who this might be right forAlzheimer's Disease HealthPartners Institute 12
Early research (Phase 1)Study completedNCT00757939What this trial is testingAssess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)Who this might be right forAlzheimer's Disease Merck Sharp & Dohme LLC 40
Not applicableUnknownNCT01958983What this trial is testingMusic Therapy to Promote Emotion and Cognition for DementiaWho this might be right forDementia Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02626572What this trial is testingEfficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive SymptomsWho this might be right forAlzheimer's Disease Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Looking for participantsNCT06534723What this trial is testingPhase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)Who this might be right forAlzheimer's Dementia Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Early research (Phase 1)Study completedNCT00607308What this trial is testingA Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 20
Early research (Phase 1)Study completedNCT01908010What this trial is testingSafety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsWho this might be right forAlzheimer's Disease AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT00357357What this trial is testingEuropean Study of HF0220 in Mild to Moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer's Disease Hunter-Fleming Ltd 40